Literature DB >> 9688319

ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha.

G Defazio1, M Trojano, D Ribatti, B Nico, M Giorelli, R De Salvia, G Russo, L Roncali, P Livrea.   

Abstract

We have studied the effect of interferon (IF) beta-1a on the basal and TNFalpha-induced intercellular adhesion molecule 1 (ICAM 1) expression and fluid phase endocytosis (FPE) of horseradish peroxidase in cultured rat brain microvascular endothelial cells. Neither basal ICAM 1 expression nor basal FPE were significantly affected by 24-72 h exposure to 1000 U/ml IFbeta-1a. ICAM 1 induction and FPE enhancement caused by 100 U/ml TNFalpha for 24 h was not influenced by simultaneous administration of 1000 U/ml IFbeta-1a. Treatment of cultures with IFbeta-1a for 48 h followed by 24-h coincubation with TNFalpha (100 U/ml) and IFbeta-1a (1000 U/ml) resulted in significant downregulation of TNFalpha-induced ICAM 1 expression and FPE. Downregulation of TNFalpha-induced ICAM 1 expression was not observed when combined treatment with TNFalpha (100 U/ml) and IFbeta-1a (1000 U/ml) for 24 h was followed by 48 h exposure to IFbeta-1a. We concluded that the blood-brain barrier endothelium may be a target of IFbeta-1a. Further, these in vitro findings may correlate with the results of recent clinical trials indicating that chronic treatment of relapsing remitting multiple sclerosis with IFbeta-1a prevents both clinical exacerbations and the appearance on Magnetic Resonance Imaging of new lesions enhanced by gadolinium which is taken up by increased transendothelial fluid phase vesicular transport.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688319     DOI: 10.1016/s0165-5728(98)00064-2

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 2.  The mechanism of action of interferon-β in relapsing multiple sclerosis.

Authors:  Bernd C Kieseier
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

3.  Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis.

Authors:  Muriel B Sättler; Sarah K Williams; Clemens Neusch; Markus Otto; Jens R Pehlke; Mathias Bähr; Ricarda Diem
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

4.  Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells.

Authors:  Dorothée Faille; Fatima El-Assaad; Andrew J Mitchell; Marie-Christine Alessi; Giovanna Chimini; Thierry Fusai; Georges E Grau; Valéry Combes
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

Review 5.  Advancing brain barriers RNA sequencing: guidelines from experimental design to publication.

Authors:  David M F Francisco; Luca Marchetti; Sabela Rodríguez-Lorenzo; Eduardo Frías-Anaya; Ricardo M Figueiredo; Peter Winter; Ignacio Andres Romero; Helga E de Vries; Britta Engelhardt; Rémy Bruggmann
Journal:  Fluids Barriers CNS       Date:  2020-08-18

6.  Activation of human monocytes after infection by human coronavirus 229E.

Authors:  Marc Desforges; Tina C Miletti; Mylène Gagnon; Pierre J Talbot
Journal:  Virus Res       Date:  2007-07-31       Impact factor: 3.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.